Skip to main content

Herpes Zoster - Prophylaxis News

Related terms: Shingles, Prophylaxis

Two Doses of Recombinant Zoster Vaccine Highly Effective

TUESDAY, Jan. 9, 2024 – Two doses of recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ), with the vaccine effectiveness (VE) of two doses waning little over four years of...

Effectiveness of Live Zoster Vaccine Wanes Over Time

MONDAY, Dec. 11, 2023 – Live zoster vaccination is initially effective against outcomes, including herpes zoster and admission for herpes zoster, but the effectiveness wanes over time, according to...

Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults

Philadelphia, London – 26 July 2021 – GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Vaccination and Prophlaxis